BL
IBDQ

Balentine LLC’s iShares iBonds Dec 2025 Term Corporate ETF IBDQ Stock Holding History

Balentine LLC’s Portfolio IBDQ Stock Details IBDQ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-25,682
Closed -$645K – 223
2025
Q4 		$645K Sell
25,682
-350,183
-93% -$8.8M 0.02% 107
2025
Q3 		$9.47M Sell
375,865
-32,158
-8% -$808K 0.35% 20
2025
Q2 		$10.3M Sell
408,023
-9,146
-2% -$230K 0.4% 19
2025
Q1 		$10.5M Buy
417,169
+168,258
+68% +$4.23M 0.44% 19
2024
Q4 		$6.24M Buy
248,911
+129,205
+108% +$3.24M 0.25% 20
2024
Q3 		$3M Buy
119,706
+30,474
+34% +$761K 0.12% 32
2024
Q2 		$2.22M Buy
89,232
+45,851
+106% +$1.14M 0.1% 34
2024
Q1 		$1.08M Buy
43,381
+34,250
+375% +$848K 0.03% 182
2023
Q4 		$226K Buy
9,131
+8,111
+795% +$199K 0.01% 457
2023
Q3 		$24.9K Hold
1,020
– – ﹤0.01% 525
2023
Q2 		$24.9K Hold
1,020
– – ﹤0.01% 531
2023
Q1 		$25K Hold
1,020
– – ﹤0.01% 570
2022
Q4 		$24.8K Buy
+1,020
New +$24.7K ﹤0.01% 603

Other funds holding IBDQ

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Balentine LLC's IBDQ Position: Q1 2026 in Review

Balentine LLC sold out of iShares iBonds Dec 2025 Term Corporate ETF (IBDQ) in Q1 2026, closing a stake of 25,682 shares — an estimated $645K sold.

Balentine LLC first reported a position in IBDQ in Q4 2022 and held it in 13 quarters. The position peaked at $10.5M in Q1 2025. 0 funds tracked by Wall St. Rank hold IBDQ as of Q1 2026.

  • Balentine LLC reported no remaining iShares iBonds Dec 2025 Term Corporate ETF position as of Q1 2026 after selling out during the quarter.
  • Balentine LLC sold 25,682 iShares iBonds Dec 2025 Term Corporate ETF shares in Q1 2026, an estimated $645K.
  • Balentine LLC first reported a position in iShares iBonds Dec 2025 Term Corporate ETF in Q4 2022 and held it in 13 quarters.
  • Balentine LLC's iShares iBonds Dec 2025 Term Corporate ETF position peaked at $10.5M in Q1 2025.
  • 0 funds tracked by Wall St. Rank held iShares iBonds Dec 2025 Term Corporate ETF as of Q1 2026.

Based on Balentine LLC's 13F filing for Q1 2026, filed 24 Apr 2026.